Last10K.com

Plus Therapeutics, Inc. (PSTV) SEC Filing S-1 IPO Report

SEC Filings

PSTV Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

PSTV Annual Reports

PSTV Quarterly Reports

PSTV Corporate News

PSTV Registration of Securities

Cytori Therapeutics, Inc.

HISTORY TOOLS
CIK: 1095981 Ticker: PSTV

View differences made from one to another to evaluate Cytori Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this S-1 Registration of Securities to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cytori Therapeutics, Inc..

Continue

Assess how Cytori Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cytori Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this S-1 Registration of Securities

Cover Page
Condensed Balance Sheets (Unaudited)
Condensed Balance Sheets (Unaudited) (Parenthetical)
Condensed Statements Of Cash Flows (Unaudited)
Condensed Statements Of Operations (Unaudited)
Condensed Statements Of Stockholders' Equity/(Deficit) (Unaudited)
Basis Of Presentation And New Accounting Standards
Basis Of Presentation And New Accounting Standards (Additional Information) (Details)
Basis Of Presentation And New Accounting Standards (Policies)
Commitments And Contingencies
Commitments And Contingencies (Tables)
Commitments And Contingencies - Additional Information (Details)
Commitments And Contingencies - Summary Of Future Minimum Annual Lease Payments Under Operating Leases (Details)
Commitments And Contingencies - Summary Of Lease Costs (Details)
Composition Of Certain Financial Statement Captions
Composition Of Certain Financial Statement Captions (Tables)
Composition Of Certain Financial Statement Captions - Accounts Payable And Accrued Expenses (Details)
Composition Of Certain Financial Statement Captions - Additional Information (Details)
Composition Of Certain Financial Statement Captions - Other Current Assets (Details)
Composition Of Certain Financial Statement Captions - Property And Equipment, Net (Details)
Employee Benefit Plan
Employee Benefit Plan - Additional Information (Details)
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Summary Of Financial Assets Measured At Fair Value On Recurring Basis (Details)
Grant Revenue
Grant Revenue - Additional Information (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Details)
Income Taxes - Deferred Tax Assets And Liabilities (Details)
Income Taxes - Reconciliation Of Total Income Tax Provision (Details)
Income Taxes - Unrecognized Tax Benefits Activity (Details)
License Agreements
License Agreements - Additional Information (Details)
Liquidity And Going Concern
Liquidity And Going Concern - Additional Information (Details)
Loss Per Share
Loss Per Share (Tables)
Loss Per Share - Schedule Of Antidilutive Securities Excluded From Diluted Income (Loss) Per Share (Details)
Organization And Operations
Organization And Operations - Additional Information (Details)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - Additional Information (Details)
Stock-Based Compensation - Stock Option Activity (Details)
Stock-Based Compensation - Summary Of Share-Based Compensation Recognized (Details)
Stock-Based Compensation - Weighted-Average Assumptions (Details)
Stockholders' Equity
Stockholders' Equity - Common Stock (Details)
Stockholders' Equity - Preferred Stock (Details)
Stockholders' Equity - Warrants (Details)
Subsequent Events
Subsequent Events - Additional Information (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies - Additional Information (Details)
Term Loan Obligations
Term Loan Obligations (Tables)
Term Loan Obligations - Additional Information (Details)
Term Loan Obligations - Term Loan Outstanding (Details)
Use Of Estimates

Material Contracts, Statements, Certifications & more

Cytori Therapeutics, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 5.1: Opinion Regarding Legality
Exhibit 10.15: Material Contract
Exhibit 23.1: Consents Of Experts And Counsel
Exhibit FILING FEES: Ex-Filing Fees
Ticker: PSTV
CIK: 1095981
Form Type: S-1 Registration of Securities
Accession Number: 0001193125-24-157500
Submitted to the SEC: Fri Jun 07 2024 5:02:00 PM EST
Accepted by the SEC: Fri Jun 07 2024
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/pstv/0001193125-24-157500.htm